Logo image of NBIX

NEUROCRINE BIOSCIENCES INC (NBIX) Stock Analyst Ratings

NASDAQ:NBIX - Nasdaq - US64125C1099 - Common Stock - Currency: USD

120.69  +4.58 (+3.94%)

After market: 120.69 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 169.5. This target is 40.44% above the current price.
NBIX was analyzed by 32 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
NBIX Historical Analyst RatingsNBIX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 10 20 30

Price Target & Forecast

Price Low Median Mean High 120.69139.38167.28169.50201.60 - 15.49% 38.60% 40.44% 67.04%
NBIX Current Analyst RatingNBIX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-02-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-10 Guggenheim Maintains Buy -> Buy
2025-02-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-07 Needham Reiterate Hold -> Hold
2025-02-07 RBC Capital Maintains Sector Perform -> Sector Perform
2025-02-07 Wedbush Maintains Outperform -> Outperform
2025-02-07 Canaccord Genuity Maintains Buy -> Buy
2025-02-07 B of A Securities Maintains Buy -> Buy
2025-02-07 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-04 Morgan Stanley Maintains Overweight -> Overweight
2025-01-30 UBS Maintains Buy -> Buy
2025-01-08 UBS Maintains Buy -> Buy
2024-12-23 Barclays Maintains Overweight -> Overweight
2024-12-23 Piper Sandler Reiterate Overweight -> Overweight
2024-12-20 Needham Reiterate Hold -> Hold
2024-12-16 Wedbush Reiterate Outperform -> Outperform
2024-12-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-11 Needham Reiterate Hold
2024-11-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-31 Needham Reiterate Hold
2024-10-30 Needham Reiterate Hold
2024-10-29 Needham Reiterate Hold
2024-10-17 BMO Capital Maintains Market Perform -> Market Perform
2024-10-10 Raymond James Reiterate Outperform
2024-10-08 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-10-04 RBC Capital Maintains Sector Perform -> Sector Perform
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-09 Barclays Maintains Overweight -> Overweight
2024-08-29 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-08-29 BMO Capital Maintains Market Perform -> Market Perform